1036765

TAGI Pharma, Inc. — FEI 3010167068

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 13, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
South Beloit, IL (United States)